Literature DB >> 15058375

Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial.

Luca Francetti1, Massimo Del Fabbro, Matteo Basso, Tiziano Testori, Roberto Weinstein.   

Abstract

BACKGROUND: A growing flow of recent evidence indicates enamel matrix derivative (EMD, Emdogain) as a useful tool for the regeneration of periodontal tissues. This prospective clinical study aimed to evaluate the efficacy of EMD combined with surgical treatment of periodontal intra-bony defects, as compared with surgery alone, up to 24 months of follow-up.
METHODS: Twenty-four intra-bony defects were treated in 24 patients in a single clinical centre. Each defect had intra-bony depth (IBD) > or = 4 mm and probing pocket depth (PPD) > or = 6 mm. Patients were randomly assigned to either test or control group. Plaque index (PI), gingival index (GI), PPD and periodontal attachment level (PAL) were assessed at baseline pre-surgical examination at the site to be treated. Full mouth plaque score (FMPS) and full mouth bleeding score (FMBS) were also evaluated. Twelve patients were treated by simplified papilla preservation flap technique (control group), while 12 patients were treated with the same surgical technique plus EMD after ethylenediamine tetraacetic acid root conditioning (test group). Any probing at the involved sites was avoided in the first year post-surgery. Radiographs were taken at baseline, 12 and 24 months after surgery using customized bite blocks. Intra-bony defect depth (IBD) and angle (IBA) were measured from X-rays by a computer-aided technique. At 12 and 24 months post-surgery, FMPS, FMBS, PI, GI, PPD, PAL and radiographic IBD and IBA were assessed. The difference between each follow-up and baseline, and between groups at each follow-up was evaluated for the above parameters by standard statistical methods.
RESULTS: In both groups, clinical and radiographic parameters were improved at either 12 or 24 months when compared with baseline. The test group displayed better outcomes when compared with the control group for IBD, PPD, and PAL gain at 12 months, and only for PAL and IBD gain at 24 months. No adverse event related to the use of EMD was reported.
CONCLUSIONS: The surgical procedure used in the present study, aiming for maximum preservation of the regenerative potential of periodontal tissues, showed per se excellent results. The use of EMD as an adjunct to periodontal surgery in the treatment of angular defects possibly enhances periodontal regeneration rate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15058375     DOI: 10.1111/j.0303-6979.2004.00437.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  10 in total

Review 1.  Gene therapeutics for periodontal regenerative medicine.

Authors:  Christoph A Ramseier; Zachary R Abramson; Qiming Jin; William V Giannobile
Journal:  Dent Clin North Am       Date:  2006-04

Review 2.  Advanced reconstructive technologies for periodontal tissue repair.

Authors:  Christoph A Ramseier; Giulio Rasperini; Salvatore Batia; William V Giannobile
Journal:  Periodontol 2000       Date:  2012-06       Impact factor: 7.589

3.  Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.

Authors:  Renata Cimões; Leógenes M Santiago; Arnaldo de França Caldas Júnior; Bruna de Carvalho Farias Vajgel; Jeniffer Perussolo; Nikolaos Donos
Journal:  Clin Oral Investig       Date:  2021-10-13       Impact factor: 3.606

Review 4.  Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.

Authors:  Marco Esposito; Maria Gabriella Grusovin; Nikolaos Papanikolaou; Paul Coulthard; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

5.  A novel flapless approach versus minimally invasive surgery in periodontal regeneration with enamel matrix derivative proteins: a 24-month randomized controlled clinical trial.

Authors:  Mario Aimetti; Francesco Ferrarotti; Giulia Maria Mariani; Federica Romano
Journal:  Clin Oral Investig       Date:  2016-04-05       Impact factor: 3.573

6.  Tissue engineering: A new vista in periodontal regeneration.

Authors:  Nymphea Pandit; Rajvir Malik; Deepa Philips
Journal:  J Indian Soc Periodontol       Date:  2011-10

7.  Root Surface Bio-modification with Erbium Lasers- A Myth or a Reality??

Authors:  Vamsi Lavu; Subramoniam Sundaram; Ram Sabarish; Suresh Ranga Rao
Journal:  Open Dent J       Date:  2015-01-30

8.  Two-year randomized clinical trial of enamel matrix derivative treated infrabony defects: radiographic analysis.

Authors:  Mariana Schutzer Ragghianti Zangrando; Daniela Chambrone; Ivan Munhoz Pasin; Marina Clemente Conde; Cláudio Mendes Pannuti; Luiz Antônio Pugliesi Alves de Lima
Journal:  BMC Oral Health       Date:  2014-12-04       Impact factor: 2.757

9.  Adjunctive Effect of Systemic Antibiotics in Regenerative/Reconstructive Periodontal Surgery-A Systematic Review with Meta-Analysis.

Authors:  Luigi Nibali; Jacopo Buti; Luigi Barbato; Francesco Cairo; Filippo Graziani; Søren Jepsen
Journal:  Antibiotics (Basel)       Date:  2021-12-22

10.  Clinical and radiographic effects of ascorbic acid-augmented platelet-rich fibrin versus platelet-rich fibrin alone in intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.

Authors:  Mohamed Talaat Elbehwashy; Manal Mohamed Hosny; Ahmed Elfana; Alaa Nawar; Karim Fawzy El-Sayed
Journal:  Clin Oral Investig       Date:  2021-04-12       Impact factor: 3.573

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.